Teva’s ESG strategy guides how we advance health and equity, minimize our impact on the planet and dedicate ourselves to quality, ethics and transparency. It drives us to be responsible in all we do - take a look at how this came to life in 2021.
Dr Riad Dirani specializes in researching the clinical, economic and human impact of non-communicable diseases (NCDs), such as heart disease, stroke, cancer, asthma and diabetes. Riad outlines how his work is helping tackle an “invisible epidemic” and how his Dad’s unexpected experience with diabetes led him to a career in the pharma industry.
TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2019 Environmental, Social and Governance (ESG) Progress Report, demonstrating the company’s social impact and responsibility performance. The report includes 2020 goals for specific topics and clear alignment with the United Nations Sustainable Development Goals. For the first time, an external reviewer validated select report content.
You are about to leave the Teva Pharmaceuticals global website
Teva Pharmaceuticals is not responsible for the accuracy or compliance with laws of information on any third party websites.